Achab; Abdelghani

Patent Applications and Registrations

Patent applications and USPTO patent grants for Achab; Abdelghani.The latest application filed is for "novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors".

Company Profile

12.14.14

Achab; Abdelghani - Melrose MA
Achab; Abdelghani - Boston MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Grant 11,319,283 - McGowan , et al. May 3, 2	2022-05-03
Substituted phenyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Grant 11,208,407 - Zhou , et al. December 28, 2	2021-12-28
Novel Substituted Biaryl Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors App 20210317091 - Han; Yongxin ; et al.	2021-10-14
Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Grant 11,111,232 - White , et al. September 7, 2	2021-09-07
Novel Substituted Tetrahydroquinolin Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors App 20210179607 - Deng; Yongqi ; et al.	2021-06-17
Substituted N'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors Grant 11,034,661 - Guo , et al. June 15, 2	2021-06-15
Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Grant 10,995,085 - Han , et al. May 4, 2	2021-05-04
Substituted n'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Grant 10,988,487 - Liu , et al. April 27, 2	2021-04-27
Novel Substituted Cyclobutylpyridine And Cyclobutylpyrimidine Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors App 20200290996 - White; Catherine M. ; et al.	2020-09-17
Novel Substituted Cyclobutylbenzene Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors App 20200277252 - McGowan; Meredeth Ann ; et al.	2020-09-03
Novel Substituted N'-hydroxycarbamimidoyl-1,2,5-oxadiazole Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors App 20200231606 - Liu; Kun ; et al.	2020-07-23
Novel Substituted Biaryl Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors App 20200216425 - Han; Yongxin ; et al.	2020-07-09
Novel Substituted Phenyl Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors App 20200216443 - Zhou; Hua ; et al.	2020-07-09
Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Grant 10,647,705 - Han , et al.	2020-05-12
Novel Substituted N'-hydroxycarbamimidoyl-1,2,5-oxadiazole Compounds As Indoleamine 2,3-dioxygenase Ido Inhibitors App 20200102278 - Guo; Liangqin ; et al.	2020-04-02
Compounds as indoleamine 2,3-dioxygenase inhibitors Grant 10,538,497 - Han , et al. Ja	2020-01-21
Novel Substituted Biaryl Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors App 20190144433 - Han; Yongxin ; et al.	2019-05-16
Novel Compounds As Indoleamine 2,3-dioxygenase Inhibitors App 20180362482 - Han; Yongxin ; et al.	2018-12-20
Indazole derivatives useful as ERK inhibitors Grant 9,351,965 - Shipps, Jr. , et al. May 31, 2	2016-05-31
Inhibitors of fatty acid binding protein (FABP) Grant 8,759,357 - Shipps, Jr. , et al. June 24, 2	2014-06-24
Indazole Derivatives Useful As Erk Inhibitors App 20130261125 - Shipps, JR.; Gerald W. ; et al.	2013-10-03
Inhibitors Of Fatty Acid Binding Protein (fabp) App 20120190696 - Shipps, JR.; Gerald W. ; et al.	2012-07-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.